BR0317249A - Método de preparar compostos de aminocianopiridina tricìclica - Google Patents

Método de preparar compostos de aminocianopiridina tricìclica

Info

Publication number
BR0317249A
BR0317249A BR0317249-0A BR0317249A BR0317249A BR 0317249 A BR0317249 A BR 0317249A BR 0317249 A BR0317249 A BR 0317249A BR 0317249 A BR0317249 A BR 0317249A
Authority
BR
Brazil
Prior art keywords
preparing
tricyclically
compounds
aminocyanopyridine compounds
aminocyanopyridine
Prior art date
Application number
BR0317249-0A
Other languages
English (en)
Inventor
David R Anderson
Emily J Reinhard
Stephen A Kolodziej
William F Vernier
Shridhar G Hegde
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of BR0317249A publication Critical patent/BR0317249A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

"MéTODO DE PREPARAR COMPOSTOS DE AMINOCIANOPIRIDINA TRICìCLICA". A presente invenção refere-se a um método de preparar compostos de aminocianopiridina os quais são capazes de inibir proteína cinase-2 ativada por proteína cinase ativada por mitogênio.
BR0317249-0A 2002-12-12 2003-12-09 Método de preparar compostos de aminocianopiridina tricìclica BR0317249A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43278302P 2002-12-12 2002-12-12
PCT/US2003/038999 WO2004055019A1 (en) 2002-12-12 2003-12-09 Method of making tricyclic aminocyanopyridine compounds

Publications (1)

Publication Number Publication Date
BR0317249A true BR0317249A (pt) 2005-11-01

Family

ID=32595084

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0317249-0A BR0317249A (pt) 2002-12-12 2003-12-09 Método de preparar compostos de aminocianopiridina tricìclica

Country Status (8)

Country Link
US (1) US6909001B2 (pt)
EP (1) EP1569938A1 (pt)
JP (1) JP2006511537A (pt)
AU (1) AU2003297743A1 (pt)
BR (1) BR0317249A (pt)
CA (1) CA2509249A1 (pt)
MX (1) MXPA05006366A (pt)
WO (1) WO2004055019A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005061519A1 (en) 2003-12-19 2005-07-07 Takeda San Diego, Inc. Kinase inhibitors
EP1778669A2 (en) 2004-08-18 2007-05-02 Takeda San Diego, Inc. Kinase inhibitors
ATE479687T1 (de) 2004-10-15 2010-09-15 Takeda Pharmaceutical Kinaseinhibitoren
EP1824498A4 (en) * 2004-11-12 2009-06-24 Massachusetts Inst Technology METHOD AND COMPOSITIONS FOR TREATING PROLIFERATIVE CELL DISEASES
US8440610B2 (en) 2004-11-12 2013-05-14 Massachusetts Institute Of Technology Mapkap kinase-2 as a specific target for blocking proliferation of P53-defective cells
US7473694B2 (en) 2005-03-17 2009-01-06 Teijin Pharma Limited Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereof
US7417053B2 (en) 2005-04-07 2008-08-26 Teijin Pharma Limited Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
SG158147A1 (en) 2006-10-09 2010-01-29 Takeda Pharmaceutical Kinase inhibitors
DE102012015572A1 (de) 2012-08-07 2014-02-13 Peter von Buengner Elektrodenendgerät für die Bioresonanztherapie und -diagnostik

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299963A (en) * 1977-03-08 1981-11-10 Takeda Chemical Industries, Ltd. 1-Azaxanthone derivatives
US5192768A (en) * 1990-09-14 1993-03-09 Kyowa Hakko Kogyo Co., Ltd. Pyrazoloquinoline derivatives
DE4039272A1 (de) * 1990-12-08 1992-06-11 Basf Ag Pyrido-anellierte 4-oxo-4h-benzopyrane, verfahren zu ihrer herstellung und ihre verwendung als antidots
US6046208A (en) * 1996-01-11 2000-04-04 Smithkline Beecham Corporation Substituted imidazole compounds
WO1997034137A2 (en) * 1996-03-12 1997-09-18 Smithkline Beecham Corporation Methods of the identification of pharmaceutically active compounds
AU8101698A (en) * 1997-07-18 1999-02-10 Novo Nordisk A/S Use of fviia or fviiai for the treatment of adverse conditions related to the fviia mediated intracellular signalling pathway
WO1999032121A1 (en) * 1997-12-19 1999-07-01 Smithkline Beecham Corporation Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses
DE19814963A1 (de) 1998-04-03 1999-10-07 Max Delbrueck Centrum MAPKAP Kinase 2-Hemmer und ihre Verwendung für die anti-inflammatorische Therapie
US6593337B1 (en) 1999-10-19 2003-07-15 Bristol-Myers Squibb Pharma Company Tricyclic compounds useful as HIV reverse transcriptase inhibitors
CA2396579A1 (en) 1999-12-29 2001-07-05 Wyeth Tricyclic protein kinase inhibitors
AU2001260081B2 (en) * 2000-05-22 2005-07-28 Leo Pharma A/S Benzophenones as inhibitors of il-1beta and tnf-alpha
US20030139435A1 (en) 2001-06-26 2003-07-24 Gulzar Ahmed N-heterocyclic inhibitors of TNF-alpha expression

Also Published As

Publication number Publication date
MXPA05006366A (es) 2005-08-29
CA2509249A1 (en) 2004-07-01
WO2004055019A1 (en) 2004-07-01
EP1569938A1 (en) 2005-09-07
US6909001B2 (en) 2005-06-21
US20040127714A1 (en) 2004-07-01
JP2006511537A (ja) 2006-04-06
AU2003297743A1 (en) 2004-07-09

Similar Documents

Publication Publication Date Title
BRPI0412894A (pt) tienopiridina e furopiridina inibidores de quinases
BR0308261A (pt) Métodos extrativos para puruficação de sucralose
BR0215622A (pt) Inibidores da dpiv com base em glutaminila
CY1109088T1 (el) Μεθοδος για την παρασκευη υποκατεστημενων ενωσεων 3-αρυλο-βουτυλ-αμινης
BRPI0412667A (pt) sìntese regiosseletiva de cci - 779
BR0305258A (pt) Inibidores de polimerase de ns5b de hcv
BR0307702A (pt) Formulações de solução contendo anticorpo
TW200519096A (en) Quinazoline analogs as receptor tyrosine kinase inhibitors
BRPI0413973A (pt) compostos
BR0102607A (pt) Compostos de difeniluréia, um processo para sua preparação e composições farmacêuticas contendo os mesmos
BR0317284A (pt) Inibidores aminocianopiridina de proteìna quinase-2 ativada com proteìna quinase ativada com mitógeno
BRPI0407282A (pt) Processo para preparação de inibidores de pirrolotriazina cinase
BR0317249A (pt) Método de preparar compostos de aminocianopiridina tricìclica
BR0301667A (pt) Processo para a preparação de polìmeros em emulsão com pureza elevada
UY27842A1 (es) Fluorobenzamidas
DE60207759D1 (de) Pyrimidotriazine als phosphataseinhibitoren
DK1680430T3 (da) Fremgangsmåder til fremstilling af form I af (S)-(+)-Clopidogrel-bisulfat
DE60312029D1 (de) Verfahren zur herstellung c-7 substituierter 5-androstene
BR0209901A (pt) Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
BRPI0517390A (pt) processo para a preparação de derivados de [1,4,5]-oxadiazepina
BR0314128A (pt) Processo para o preparo de intermediários uteis para a sìntese de inibidores de tubulina
UA90659C2 (ru) Аналоги хиназолина как ингибиторы рецепторных тирозинкиназ
BR0113170A (pt) Processo para a preparação de dinapsolina
BRPI0411652A (pt) processo para a preparação de derivados de espirobenzoazepina substituìdos não-peptìdicos
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2073 DE 28/09/2010.